Posts by Sandra Ansanay-Alex
HepaVue Awarded By FIT
HepaVue created the world’s first virtual reality liver biopsy to diagnose liver disease. The CHF 100,000 Tech Seed loan granted by the Foundation pour l’Innovation Technologique (FIT) will enable the start-up to finalise its artificial intelligence software and begin production of its radiotracers. Worldwide, more than 2 billion people are affected by chronic,…
Read MoreAtinary Technologies: a new lab in the U.S. and a partnership with Takeda
The Swiss Health Valley company launches its self-driving Data factory: the AI-driven Laboratory for High-Quality Data and Molecules Generation in collaboration with Takeda Pharmaceuticals. Atinary Technologies, in partnership with Takeda Pharmaceuticals, the largest pharmaceutical company in Japan, has launched a state-of-the-art AI-driven facility in Kendall Square, Cambridge, Massachusetts. Known as the Self-driving Laboratory™, this…
Read MoreXemperia wins the IFF Start-Up Award
The Innovation Fribourg Freiburg (IFF) 2024-2025 Prizes were awarded on 6 November 2024. Xemperia, a University of Fribourg spin-off won the Start-Up Award worth CHF 30’000. Xemperia won the highest number of votes in a selection process that combined the choices of the jury (one-third) and the public (two-thirds). Since the announcement of…
Read MoreThe Advanced Science Building:A New Impetus for Basic Research at EPFL
EPFL is investing CHF 200 million in an innovative building specially designed to meet the extreme demands of cutting-edge deep tech research, in the fields of quantum physics, nanotechnology, biology, chemistry and materials. In fields where measurements must be perfectly isolated from outside noise, the challenge is to create an environment that is free from…
Read MoreImpli partners with Bayer
Bayer announced a partnership with Impli, a Biopôle-based innovative, femtech start-up in precision care. Impli’s goal is to advance women’s health and deliver the first real-time hormone monitoring device – making fertility more accessible, safer and more successful. With hormones playing a critical role in many of our body’s systems and functions, real-time…
Read MoreMassChallenge Switzerland Awards
The MassChallenge Switzerland Awards 2024 ceremony was held in Lausanne on 1 November. This non-equity start-up accelerator, honoured 12 innovative start-ups. The winners received a total of CHF 400,000 for their solutions that have a positive impact on society. The ceremony, attended by over 400 guests and broadcast around the world, also honoured…
Read MoreONWARD and Aspivix listed in TIME magazine’s Best Inventions of 2024
Two Western Switzerland medtech companies, Aspivix and ONWARD Medical, have been named among TIME magazine’s Best Inventions of 2024, each recognized for innovations that could revolutionize healthcare for millions. Aspivix addresses a long-overlooked issue in women’s health. Typically, IUD insertions and other uterine procedures require the use of a tenaculum, a sharp instrument…
Read MoreFluoSphera expands into the testing of Antibody-Drug-Conjugates (ADCs)
FluoSphera, a Geneva-based leader in systemic drug discovery, is proud to announce its strategic expansion into the testing of Antibody-Drug-Conjugates (ADCs). By deploying new predictive tools based on its proprietary technology, FluoSphera aims to provide ‘first-in-human’ in vitro data on ADCs in development, in order to optimise their properties and increase their clinical success rate.…
Read MorePerivision VisionOne gets CE-Mark
Perivision has received the EU CE-certification for its 1st medical software product VisionOne. PeriVision, an innovative spin-off from the University of Bern and the University Hospital Bern, and now based at Biopôle in Lausanne, has received the EU CE-certification for its 1st medical software product VisionOne. VisionOne addresses the large unmet clinical need…
Read MoreLa Prairie launches the Longevity Fund
Clinique La Prairie (CLP), global leader in longevity since 1931, announces the LONGEVITY FUND, an endeavour to identify and invest in companies that revolutionize the landscape of ageing, health, and wellbeing. The Fund will focus on driving science-based advancements in longevity, guided by four core mission pillars: Medical Care, Nutrition, Movement, and Wellbeing.…
Read More